Open Access
Substance Abuse: Research and Treatment
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q2
WOS
Q3
Impact factor
2
SJR
0.828
CiteScore
2.7
Categories
Psychiatry and Mental Health
Areas
Medicine
Years of issue
2008-2023
journal names
Substance Abuse: Research and Treatment
SUBST ABUS-RES TREAT
Top-3 citing journals

Substance Use and Misuse
(72 citations)

Frontiers in Psychiatry
(61 citations)
Top-3 organizations

University of Oslo
(16 publications)

Brown University
(15 publications)

Rhode Island Hospital
(11 publications)

Boston University
(4 publications)

University at Buffalo, State University of New York
(4 publications)

New York University
(3 publications)
Most cited in 5 years
Found
Publications found: 1113
Cutting-edge bioorthogonal chemistry: Innovations, practical applications, and emerging trends
Chetry A.B.
Bioorthogonal chemistry has emerged as a pivotal field in molecular science, offering transformative tools for applications in drug discovery, imaging, and molecular biology. This review provides a comprehensive analysis of recent advancements in bioorthogonal chemistry, emphasizing key innovations, practical applications, and future research directions. We explore state-of-the-art bioorthogonal reactions, including Staudinger ligation, strain-promoted azide-alkyne cycloaddition (SPAAC), and tetrazine ligation, detailing their mechanisms, advantages, and limitations. The review highlights significant innovations such as novel fluorogenic probes, improved catalysts, and enhanced reaction conditions that have expanded the utility and efficiency of these reactions. Practical applications are examined, showing how these advances have revolutionized fields like live-cell imaging, targeted drug delivery, and molecular labeling. Looking to the future, we discuss emerging trends and potential research avenues, including the integration of bioorthogonal chemistry with other advanced technologies and the development of new reaction methodologies. This review provides a detailed overview of the current state of bioorthogonal chemistry and outlines its future potential, serving as a valuable resource for researchers and practitioners in the field.
Synthesis and crystal structure determination of a new 1D polymer adduct of 1,2-di(pyridin-4-yl)ethane, based on B-N dative bonded eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane
Bull O.S., Don-Lawson C.
A novel 1D polymer of 1,2-di(pyridin-4-yl)ethane (L1), connected via B-N dative-bonded adduct with an eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane [Ph6B2Si2O4]·L1 was synthesized and characterized. The new compound [Ph6B2Si2O4]·L1 was prepared by the reaction of cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane and bis(pyridyl)ethane in a mixture of diethyl ether and petroleum ether solvents at reflux. The 1D polymer [Ph6B2Si2O4]·L1 was characterized by single-crystal X-ray diffraction, nuclear magnetic resonance, and FT-IR spectroscopy. The single crystal X-ray diffraction studies reveal that the aforementioned compound crystalized in the monoclinic crystal system with a centrosymmetric space group of P21/n (no. 14), a = 16.5378(4) Å, b = 12.6201(3) Å, c = 20.4904(5) Å, β = 96.689(2)°, V = 4247.43(18) Å3, Z = 4, T = 173.0 K, μ(MoKα) = 0.130 mm-1, Dcalc = 1.233 g/cm3, 14630 reflections measured (4.96° ≤ 2Θ ≤ 56.424°), 8424 unique (Rint = 0.0235, Rsigma = 0.0460) which were used in all calculations, the final R1 was 0.0455 (I > 2σ(I)) and wR2 was 0.1201 (all data). Furthermore, the compound exhibits various noncovalent interactions in the crystal packing, such as intermolecular and intramolecular, as well as hydrogen bonding. This study demonstrates the potential for making novel materials via the combination of cyclodiboradisiloxanes (Lewis acid) and nitrogen-containing ligands (Lewis bases).
Tetrachloro-(acetylacetonato)stannate(IV) and tri-iodocadmate(II) stabilized by a heptacyclic cation: Synthesis, characterization, and crystal structure
Ndiolene A., Diop T., Boye M.S., Diasse-Sarr A.
The tin (IV) and cadmium (II) complexes were synthesized in mixture, the ligand 4,4'-(ethane-1,2-diylbis(azanylylidene))bis(pent-2-en-2-ol), and the halide metal (SnCl2 or CdI2). Complex synthesis involves partial hydrolysis of the ligand followed by condensation cyclization. The new tin complex obtained crystallizes in the monoclinic space group P21/n with a = 8.5468(5) Å, b = 17.9907(9) Å, c = 12.7227(7) Å, β = 94.220(5) °, V = 1950.98(18) Å3 and Z = 4. The asymmetric unit consists of an anion tetrachloro-(acetylacetonato)stannate(IV) and a heptacyclic cation. The geometry of the complex is octahedral with cis coordination of the two oxygens of the acetylacetone. The cadmium complex crystallizes in the orthorhombic space group Pbca with a = 14.7395(9) Å, b = 8.5914(5) Å, c = 23.2825(13) Å, V = 2948.3(3) Å3, Z = 8. The geometry around cadmium is a deformed tetrahedron. The heptacyclic cation and the anionic complex are interconnected through hydrogen bonding interactions, specifically N–H···Cl or N–H···I, forming a network.
Synthesis, characterization, crystal structure and antioxidant activity of N-(3-chloropropionyl)-N'-(4-methoxyphenyl)thiourea
Abosadiya H.M.
In the present work, a new carbonoyl thiourea derivative, N-(3-chloropropionyl)-N'-(4-methoxyphenyl)thiourea, was synthesized by the reaction of 3-chloropropionyl isothiocyanate with 4-methoxyaniline in acetone solution. The newly synthesized compound was characterized by FT-IR, 1H NMR, and 13C NMR spectroscopic techniques. X-ray crystallographic studies indicate that the compound crystallized in the triclinic crystal system with space group P-1 and unit cell dimension are a = 10.2262(6) Å, b = 11.5007(7) Å, c = 12.6116(8) Å, α = 72.253(2)°, β = 66.348(2)°, γ = 88.099(2)°, Z = 4 and V = 1287.22 (14) Å3. Strong intramolecular O-H···N hydrogen bonds are present that form a six-member pseudo-ring S(6). In the crystal structure, the molecules are linked by N-H···O, N-H···S, and C-H···O intermolecular hydrogen bonding interactions formed infinite one-dimensional chains with an R22(8) and R22(12) rings motif of molecules. The antioxidant test using the DPPH method showed that the compound exhibits a good antioxidant activity of about 80%.
Redox behavior of aliphatic hydroxamic acid and its iron(III) complexes
Sow I.S., Vandeput M., Gelbcke M., Dufrasne F.
N-Hydroxydodecanamide (HA12) and its trihydroxamato-iron(III) complex (HA12Fe3) have been synthesized and characterized by various methods including structural determination by single crystal X-ray diffraction and cyclic voltammetry (CV). In order to complete our previous CV study on HA12 and its complexes, our aim was to investigate the variation in redox potential upon changes in concentration and pH. The redox couples previously observed with HA12 and HA12Fe3 at 100 µM shifts towards less positive values when the concentration or pH of the solution increases. These results indicate that oxidation is easier when concentrations are higher and in basic media. The slopes of -0.06 V/pH (in agreement with the theoretical data) and -0.077 V/pH (slightly higher than the theoretical slope) were observed for HA12 and HA12Fe3, respectively. This observation would explain the slower oxidation of HA12Fe3 than HA12.
Graphical Contents
Arslan H.
Graphical Contents
Methods for synthesizing hydroxamic acids and their metal complexes
Sow I.S.
In previously published works, the antibacterial, antifungal, antimycobacterial and anticancer activities of hydroxamic acids (HA) and their complexes were reported. Our recently published work shows that aliphatic HA with a number of carbon atoms equal to 12 (C12) and its Fe(II), Fe(III), Ni(II), Cu(II) and Zn(II) complexes are significantly active against bacteria (Staphylococcus aureus, Escherichia coli), fungal (Candida albicans) and mycobacteria (Mycobacterium smegmatis). Furthermore, the inhibitory activities against biofilms of Mycobacterium tuberculosis, Mycobacterium bovis BCG, Mycobacterium marinum and Pseudomonas aeruginosa were observed with a large number of HA and their complexes. Suberoylanilide HA and resminostat were approved to treat cutaneous T cell lymphoma and in clinical trials to treat advanced hepatocellular carcinoma, respectively. In view of the interesting biological properties of this family of chemical compounds, the synthesis of HA has been reported in numerous research articles in recent years but this is the second review article dedicated to their synthetic methods and the first review for their complexes. The aim of this review is to highlight optimal and rational methods for the synthesis of HA and their complexes. HA are obtained in near-quantitative yields from carboxylic acid, ethyl chloroformate, N-methylmorpholine and hydroxylamine. As for their complexes, the synthesis methods described are fairly similar and would all appear to be optimal. The main criteria are the number of equivalents of HA, the type of metal salt or solvent used and the reaction conditions.
Environmentally benign synthesis of substituted iodinated flavones as precursors for prenyl-/geranyl flavones from the corresponding chalcones
Khan S., Liza U.A., Banik D., Aman M.A., Happy K., Arjaya A.C., Hossain M.M.
Flavones have biological properties because of the existence of oxoheterocyclic ring moieties, and day by day create research interest areas because of their important biological activity. Iodine-substituted flavones were synthesized from the corresponding chalcones through an exhaustive iodination reaction. Generally, it is seen that halogenated flavones show better biological activity. Moreover, the introduction of iodine in the ring moiety facilitates the incorporation of highly active side chains, such as prenyl and geranyl groups through the formation of C-C bonds by numerous coupling reactions such as Sonogashira coupling. To achieve such target molecules, a planned chemical synthesis was conducted. For comparison, microwave irradiation (MWI) and conventional heating (CH) methods were used to synthesize a series of iodine-substituted flavone compounds with different substitutes (4a-d) from their corresponding chalcones (3a-d). Unfortunately, 3e chalcone (1-hydroxynapthalene substituted flavone) did not convert to 4e flavones. In the microwave method, a notable decrease in time required in the reaction and an increase in % yield of the reaction were remarked. Characterization and conformation of all synthesized compounds were done using ultraviolet, infrared, and nuclear magnetic resonance spectroscopy and elemental analysis.
Physicochemical characterization of siliceous sands of Seme-Podji/Benin: An application for the synthesis of silica particles
Glitho H.A., Osseni S.A., Bonou S.S., Plaisier J., Gigli L., Sagbo E., Chouti W.K.
In order to valorize locally available natural resources, the silica sand in the commune of Sèmè-Podji in Republic of Benin was characterized. The results obtained by particle size, chemical analysis, X-ray diffraction (XRD), and FT-IR analysis confirmed that these sands contain a high percentage of silicon dioxide, with a value approximately equal to 90 wt.%. Low Fe2O3 and Al2O3 content (<1 wt.%) and minor oxides such as K2O, Na2O, TiO2, and P2O5 (<0.6%) were also present. The size distributions of the particles show that the largest portion of the sand is found between 63 and 125 μm. This portion represents the one that contains the most silica. From this sand, silica particles were synthesized by the sol-gel method. The results obtained by X-ray diffraction (XRD), FT-IR analysis, and scanning electron microscopy (SEM) reveal the formation of pure amorphous silica.
Synthesis and in vitro evaluation of tetrazole containing 1,5-benzothiazepines as new anticancer, antitubercular, antibacterial, and antifungal agents
Suman A.K., Anu A., Singh B.
Heterocyclic scaffolds have attracted great attention of organic chemists and medicinal chemists, also because of their wide range of synthetic applicability and broad spectrum of biological profile. Therefore, in the present research work, a series of tetrazole containing 1,5-benzothiazepines have been synthesized for evaluation of their biological activities to determine the potential therapeutic profile of these compounds across various medicinal domains. Of the synthesized compounds, five compounds (6f, 8e, 8f, 8g, and 8h) have been screened for anticancer, antitubercular, antibacterial, and antifungal activities. After evaluation of these biological activities, it was found that these compounds possess very limited anticancer activity, moderate antibacterial and antifungal activity, and very strong antitubercular activity, which indicate their great pharmacological applications as subjects for future investigations of novel therapeutic agents for the treatment of tuberculosis.
Synthesis and characterization of a novel eight-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane and 4,4ˈ-bipyridine, 1D adduct
Bull O.S., Don-Lawson C., Nweke-Maraizu U.
Simple adducts of cyclo-diboradisiloxanes (Lewis acid) and amines (Lewis base) have been reported in the literature. However, the method for the synthesis of an 8-membered cyclo-diboratetrasiloxane, as well as its adducts, was modified in this report to save cost and achieve new results. In the literature, the synthesis of cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane (Ph6B2Si2O4) (3) has been reported using diphenylsilanediol and phenylboronic acid and a Dean-Stark apparatus for the removal of water. However, in this study, molecular sieves were used for the facile removal of water, and the crude product recrystallized from diethyl ether and petroleum ether (3:1 ratio) to give compound 3. Compound 3 was reacted with 4,4’-bipyridine in a mixture of diethyl ether and petroleum ether solvents at reflux to give a 1D polymer [Ph6B2Si2O4]·L1 (4). Furthermore, compound 4 was characterized with various characterization methods such as single-crystal XRD, nuclear magnetic resonance, and FT-IR spectroscopy. The single crystal X-ray diffraction studies shows that the title compound crystalizes in the triclinic crystal system in the centrosymmetric space group P-1, a = 10.9372(4) Å, b = 18.4221(6) Å, c = 19.4697(6) Å, α = 70.533(3)°, β = 86.476(3)°, γ = 88.517(3)°, V = 3691.6(2) Å3, Z = 2, T = 173.0 K, μ(MoKα) = 0.122 mm-1, Dcalc = 1.204 g/cm3, 21463 reflections measured (5.196° ≤ 2Θ ≤ 56.45°), 14525 unique (Rint = 0.0185, Rsigma = 0.0483) which were used in all calculations, the final R1 was 0.0721 (I > 2σ(I)) and wR2 was 0.2143 (all data) with the 8-membered cyclo-1,3,3,5,7,7-hexaphenyl-1,5-dibora-3,7-disiloxane (Ph6B2Si2O4) (3) configuration.
IgG neutralization potential of COVISHIELD™ vaccinated individual’s sera after booster vaccination: Longitudinal and prospective cohort study
Jagadeesan N., Kumar P., Gowda N.P., Karur K., Nanjappa M.C., Kumari P., Kumar H.T.
The novel SARS-CoV-2 (COVID-19) has caused widespread human turmoil by posing challenges concerning infection prevention, disease diagnosis, and treatment. Several approved vaccines including Sinovac (CoronaVac), COVISHIELD™ (Oxford/AstraZeneca formulation), Janssen (Johnson & Johnson), Sputnik V (Gamaleya), Covaxin (Bharat Biotech), Pfizer (BNT162b2), and others are being used to combat COVID-19. It is crucial to evaluate the kinetics of SARS-CoV-2 antibodies to predict the possibility of reinfection and the longevity of vaccination protection. There is a lack of data on longitudinal humoral antibody dynamics following two and three doses of the SARS-CoV-2 vaccination ChAdOx1-nCOV (COVISHIELDTM) in Indians. Thus, concerns about the efficacy of current vaccines have been raised by a sharp rise in coronavirus disease 2019 (Covid-19) cases caused by sub-variants of SARS-CoV-2 (Severe acute respiratory syndrome corona virus 2) in communities that have received massive vaccinations. The relative immunogenicity and safety of various COVID-19 immunizations administered as a third (booster) dose are not well known. We examined the reactogenicity and immunogenicity of the COVID-19 vaccine as a third dose after two doses of COVISHIELDTM to produce data to optimize the selection of booster vaccinations. After three doses of the COVID-19 vaccine, we evaluated the sera of COVISHIELDTM vaccine recipients for their ability to neutralize the virus. Primary immunization with two doses of COVISHIELDTM vaccine recipients provided significant protection against symptomatic disease caused by the SARS-CoV-2 variants. A COVISHIELDTM vaccine booster vaccine recipient substantially increased protection. The immunization findings showed a significant difference (p ≥ 0.001) between the COVID-19 naive vaccine (n = 438) and the sera of COVID-19-positive recovered subjects (n = 371) who received three doses of COVISHIELDTM. Our findings reveal that anti-RBD antibodies persist over time, which may reduce the probability of reinfection. A three-dose vaccination (n = 53) increases defense against variations by noticeably increasing cross-neutralizing antibody titers. Particularly against variants with antibody escape mutations.
Aqueous hydrotropes: An efficient and reusable catalyst for the synthesis of 3-carboxy-coumarin motifs at room temperature
Baviskar P.D., Kale A.D., Mahire V.N., Gosavi S.D., Dalal D.S., Mahulikar P.P.
The coumarin moiety plays an important role in the large number of natural products possessing different kinds of biological diversity. Coumarin carboxylic acids show a wide range of biological activities in the pharmaceutical and agricultural fields. Knoevenagel condensation is one of the important reaction pathways for synthesizing coumarin derivatives, and many methodologies have been developed to synthesize this class of compounds. A more environmentally friendly method of synthesizing 3-carboxy coumarins has been successfully carried out using 50% aqueous NaPTS hydrotropes at room temperature, along with various substituted 2-hydroxy benzaldehydes and Meldrum’s acid. This process involves Knoevenagel condensation followed by intramolecular cyclization, providing better product yields (78-95%).
Graphical Contents
Arslan H.
Graphical Contents
Single and mixed dithiocarbamato metal(III) complexes (Co, Rh, and Ir): Crystal and molecular structure description and interplay
Shotonwa I.O., Oduwole A.P., Agosu O.M., Yusuf A.F., Eze S.O.
This review focuses on the crystal and molecular structures of single and mixed dithiocarbamate ligands of cobalt, rhodium, and iridium in the +3 oxidation state. The complexities of their chelating and bridging modes come into play through modification of the substituents on the carbamate nitrogen atoms of the ligands and additional coordination of secondary phosphino-containing ligands, culminating in various applications such as biological, analytical, medicine, and catalysis. Other considerations include the geometrical coordination environments around the metal centres and their comparison with isostructural congeners. The distortions around the metal centres and their subsequent effects on the symmetries of bonds in the primary and secondary coordination spheres are discussed. The trans-effects of secondary P-ligands and their effects on geometrical alignment and structural stability have become valuable yardsticks in analyzing structural modifications and stabilities.
Top-100
Citing journals
10
20
30
40
50
60
70
80
|
|
Substance Use and Misuse
72 citations, 3.01%
|
|
International Journal of Environmental Research and Public Health
68 citations, 2.85%
|
|
Frontiers in Psychiatry
61 citations, 2.55%
|
|
Drugs: Education, Prevention and Policy
34 citations, 1.42%
|
|
Journal of Substance Use
33 citations, 1.38%
|
|
Addiction
31 citations, 1.3%
|
|
Substance Abuse: Research and Treatment
29 citations, 1.21%
|
|
International Journal of Mental Health and Addiction
28 citations, 1.17%
|
|
Journal of Substance Use and Addiction Treatment
28 citations, 1.17%
|
|
Journal of Psychoactive Drugs
23 citations, 0.96%
|
|
Journal of Drug Issues
22 citations, 0.92%
|
|
Drug and Alcohol Dependence
20 citations, 0.84%
|
|
Current Addiction Reports
20 citations, 0.84%
|
|
Frontiers in Pharmacology
19 citations, 0.8%
|
|
Harm Reduction Journal
19 citations, 0.8%
|
|
Frontiers in Psychology
18 citations, 0.75%
|
|
Substance Abuse
18 citations, 0.75%
|
|
Addictive Behaviors
17 citations, 0.71%
|
|
Nicotine and Tobacco Research
16 citations, 0.67%
|
|
BMC Public Health
16 citations, 0.67%
|
|
Addiction Research and Theory
16 citations, 0.67%
|
|
NAD Nordic Studies on Alcohol and Drugs
14 citations, 0.59%
|
|
International Journal of Drug Policy
14 citations, 0.59%
|
|
BMJ Open
14 citations, 0.59%
|
|
Alcoholism: Clinical and Experimental Research
13 citations, 0.54%
|
|
Substance Abuse: Treatment, Prevention, and Policy
13 citations, 0.54%
|
|
Journal of Addictive Diseases
13 citations, 0.54%
|
|
Frontiers in Public Health
13 citations, 0.54%
|
|
Psychopharmacology
13 citations, 0.54%
|
|
Addiction Biology
13 citations, 0.54%
|
|
PLoS ONE
13 citations, 0.54%
|
|
American Journal of Drug and Alcohol Abuse
12 citations, 0.5%
|
|
Scientific Reports
12 citations, 0.5%
|
|
Addiction science & clinical practice
12 citations, 0.5%
|
|
Health and Justice
11 citations, 0.46%
|
|
Alcohol and Alcoholism
11 citations, 0.46%
|
|
Journal of Ethnicity in Substance Abuse
11 citations, 0.46%
|
|
Cureus
11 citations, 0.46%
|
|
Journal of Clinical Medicine
11 citations, 0.46%
|
|
JMIR Research Protocols
11 citations, 0.46%
|
|
Brain Sciences
10 citations, 0.42%
|
|
Drug and Alcohol Dependence Reports
10 citations, 0.42%
|
|
American Journal on Addictions
9 citations, 0.38%
|
|
Journal of General Internal Medicine
9 citations, 0.38%
|
|
Frontiers in Behavioral Neuroscience
9 citations, 0.38%
|
|
Journal of American College Health
9 citations, 0.38%
|
|
Maternal and Child Health Journal
9 citations, 0.38%
|
|
JAMA network open
8 citations, 0.33%
|
|
Alcoholism Treatment Quarterly
8 citations, 0.33%
|
|
Drug and Alcohol Review
8 citations, 0.33%
|
|
Pain Medicine
8 citations, 0.33%
|
|
Journal of Medical Internet Research
8 citations, 0.33%
|
|
European Addiction Research
8 citations, 0.33%
|
|
JMIR Formative Research
8 citations, 0.33%
|
|
Frontiers in Pediatrics
7 citations, 0.29%
|
|
BMC Psychiatry
7 citations, 0.29%
|
|
Healthcare
7 citations, 0.29%
|
|
International Journal of Molecular Sciences
7 citations, 0.29%
|
|
Addictive Behaviors Reports
7 citations, 0.29%
|
|
Journal of Social Work Practice in the Addictions
7 citations, 0.29%
|
|
Journal of Psychopharmacology
7 citations, 0.29%
|
|
Contemporary Drug Problems
7 citations, 0.29%
|
|
Molecules
6 citations, 0.25%
|
|
Journal of Community Psychology
6 citations, 0.25%
|
|
Journal of Addiction Medicine
6 citations, 0.25%
|
|
Journal of Dual Diagnosis
6 citations, 0.25%
|
|
Annals of Internal Medicine
6 citations, 0.25%
|
|
Qualitative Health Research
6 citations, 0.25%
|
|
BMC Health Services Research
6 citations, 0.25%
|
|
Mental Health and Physical Activity
6 citations, 0.25%
|
|
Psychiatric Services
6 citations, 0.25%
|
|
SSRN Electronic Journal
6 citations, 0.25%
|
|
Substance Abuse and Rehabilitation
6 citations, 0.25%
|
|
Community Mental Health Journal
5 citations, 0.21%
|
|
International Journal of Mental Health Nursing
5 citations, 0.21%
|
|
British Journal of Clinical Pharmacology
5 citations, 0.21%
|
|
Epidemiologic Reviews
5 citations, 0.21%
|
|
Alcohol
5 citations, 0.21%
|
|
Review Journal of Autism and Developmental Disorders
5 citations, 0.21%
|
|
Eating and Weight Disorders
5 citations, 0.21%
|
|
Journal of Interpersonal Violence
5 citations, 0.21%
|
|
Prevention Science
5 citations, 0.21%
|
|
International Journal of Offender Therapy and Comparative Criminology
5 citations, 0.21%
|
|
Victims and Offenders
5 citations, 0.21%
|
|
European Child and Adolescent Psychiatry
5 citations, 0.21%
|
|
Military Medicine
5 citations, 0.21%
|
|
Children
5 citations, 0.21%
|
|
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
5 citations, 0.21%
|
|
Tobacco Use Insights
5 citations, 0.21%
|
|
Alcohol Clinical and Experimental Research
5 citations, 0.21%
|
|
Health Promotion International
4 citations, 0.17%
|
|
Issues in Mental Health Nursing
4 citations, 0.17%
|
|
Advances in Dual Diagnosis
4 citations, 0.17%
|
|
Journal of Youth and Adolescence
4 citations, 0.17%
|
|
BioMed Research International
4 citations, 0.17%
|
|
European Archives of Psychiatry and Clinical Neuroscience
4 citations, 0.17%
|
|
International Review of Psychiatry
4 citations, 0.17%
|
|
International Journal of Neuropsychopharmacology
4 citations, 0.17%
|
|
Aging and Mental Health
4 citations, 0.17%
|
|
Frontiers in Neuroscience
4 citations, 0.17%
|
|
Show all (70 more) | |
10
20
30
40
50
60
70
80
|
Citing publishers
50
100
150
200
250
300
350
400
450
|
|
Taylor & Francis
408 citations, 17.08%
|
|
Springer Nature
405 citations, 16.95%
|
|
Elsevier
250 citations, 10.46%
|
|
Wiley
230 citations, 9.63%
|
|
SAGE
223 citations, 9.33%
|
|
Frontiers Media S.A.
154 citations, 6.45%
|
|
MDPI
147 citations, 6.15%
|
|
Oxford University Press
83 citations, 3.47%
|
|
JMIR Publications
55 citations, 2.3%
|
|
Ovid Technologies (Wolters Kluwer Health)
31 citations, 1.3%
|
|
Emerald
24 citations, 1%
|
|
Cold Spring Harbor Laboratory
18 citations, 0.75%
|
|
BMJ
18 citations, 0.75%
|
|
American Medical Association (AMA)
17 citations, 0.71%
|
|
Mary Ann Liebert
15 citations, 0.63%
|
|
Research Square Platform LLC
15 citations, 0.63%
|
|
Public Library of Science (PLoS)
13 citations, 0.54%
|
|
Walter de Gruyter
11 citations, 0.46%
|
|
Hindawi Limited
10 citations, 0.42%
|
|
S. Karger AG
10 citations, 0.42%
|
|
American Psychiatric Association Publishing
7 citations, 0.29%
|
|
American College of Physicians
6 citations, 0.25%
|
|
AOSIS
6 citations, 0.25%
|
|
Bentham Science Publishers Ltd.
5 citations, 0.21%
|
|
Association of Military Surgeons of the US
5 citations, 0.21%
|
|
Social Science Electronic Publishing
5 citations, 0.21%
|
|
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
5 citations, 0.21%
|
|
Baishideng Publishing Group
5 citations, 0.21%
|
|
IntechOpen
5 citations, 0.21%
|
|
American Chemical Society (ACS)
4 citations, 0.17%
|
|
Georg Thieme Verlag KG
4 citations, 0.17%
|
|
Medknow
4 citations, 0.17%
|
|
CAIRN
4 citations, 0.17%
|
|
IGI Global
4 citations, 0.17%
|
|
Consortium Erudit
4 citations, 0.17%
|
|
Cambridge University Press
3 citations, 0.13%
|
|
Royal Society of Chemistry (RSC)
3 citations, 0.13%
|
|
American Society of Health-System Pharmacists
3 citations, 0.13%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
3 citations, 0.13%
|
|
Science Alert
3 citations, 0.13%
|
|
Akademiai Kiado
3 citations, 0.13%
|
|
College of Psychiatric and Neurologic Pharmacists
3 citations, 0.13%
|
|
Guilford Publications
3 citations, 0.13%
|
|
Southern Medical Association
3 citations, 0.13%
|
|
Springer Publishing Company
2 citations, 0.08%
|
|
AME Publishing Company
2 citations, 0.08%
|
|
Society for Neuroscience
2 citations, 0.08%
|
|
European Society of Traumatic Stress Studies (ESTSS)
2 citations, 0.08%
|
|
Annual Reviews
2 citations, 0.08%
|
|
Jaypee Brothers Medical Publishing
2 citations, 0.08%
|
|
F1000 Research
2 citations, 0.08%
|
|
Hogrefe Publishing Group
2 citations, 0.08%
|
|
SLACK
2 citations, 0.08%
|
|
AMO Publisher
2 citations, 0.08%
|
|
American Marketing Association
1 citation, 0.04%
|
|
John Benjamins Publishing Company
1 citation, 0.04%
|
|
1 citation, 0.04%
|
|
American Society of Clinical Oncology (ASCO)
1 citation, 0.04%
|
|
Pharmaceutical Society of Japan
1 citation, 0.04%
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 citation, 0.04%
|
|
American Physiological Society
1 citation, 0.04%
|
|
King Saud University
1 citation, 0.04%
|
|
AIP Publishing
1 citation, 0.04%
|
|
The Royal Society
1 citation, 0.04%
|
|
1 citation, 0.04%
|
|
Centers for Disease Control and Prevention (CDC)
1 citation, 0.04%
|
|
American Society for Pharmacology and Experimental Therapeutics
1 citation, 0.04%
|
|
Nakladatelske Stredisko CLSJE Purkyne
1 citation, 0.04%
|
|
American Academy of Pediatrics
1 citation, 0.04%
|
|
American Society of Tropical Medicine and Hygiene
1 citation, 0.04%
|
|
American Speech Language Hearing Association
1 citation, 0.04%
|
|
Association for Computing Machinery (ACM)
1 citation, 0.04%
|
|
Chulalongkorn University
1 citation, 0.04%
|
|
Western University
1 citation, 0.04%
|
|
Korean Society of Otorhinolaryngology
1 citation, 0.04%
|
|
Universidad de La Sabana
1 citation, 0.04%
|
|
Masaryk University Press
1 citation, 0.04%
|
|
The Endocrine Society
1 citation, 0.04%
|
|
Korean Society of Environmental Risk Assessment and Health Science
1 citation, 0.04%
|
|
Revue Sante Mentale au Quebec
1 citation, 0.04%
|
|
American Economic Association
1 citation, 0.04%
|
|
North Carolina Medical Society
1 citation, 0.04%
|
|
Unisa Press
1 citation, 0.04%
|
|
Pasteur Institute of Iran
1 citation, 0.04%
|
|
Korea Centers for Disease Control and Prevention
1 citation, 0.04%
|
|
Wilfrid Laurier University Press
1 citation, 0.04%
|
|
eLife Sciences Publications
1 citation, 0.04%
|
|
Academic Journals
1 citation, 0.04%
|
|
Canadian Science Publishing
1 citation, 0.04%
|
|
American Psychological Association (APA)
1 citation, 0.04%
|
|
Negah Scientific Publisher
1 citation, 0.04%
|
|
PANORAMA Publishing House
1 citation, 0.04%
|
|
Scientific Research Publishing
1 citation, 0.04%
|
|
University of Toronto Press Inc. (UTPress)
1 citation, 0.04%
|
|
Centers for Disease Control MMWR Office
1 citation, 0.04%
|
|
RCNi
1 citation, 0.04%
|
|
Toplum ve Sosyal Hizmet
1 citation, 0.04%
|
|
South Florida Publishing LLC
1 citation, 0.04%
|
|
The Japanese Psychological Association
1 citation, 0.04%
|
|
Center for Strategic Studies in Business and Finance SSBFNET
1 citation, 0.04%
|
|
Show all (70 more) | |
50
100
150
200
250
300
350
400
450
|
Publishing organizations
2
4
6
8
10
12
14
16
|
|
University of Oslo
16 publications, 4.2%
|
|
Brown University
15 publications, 3.94%
|
|
Rhode Island Hospital
11 publications, 2.89%
|
|
Oslo University Hospital
10 publications, 2.62%
|
|
Harvard University
10 publications, 2.62%
|
|
University of California, Los Angeles
10 publications, 2.62%
|
|
Boston University
8 publications, 2.1%
|
|
University of California, San Francisco
8 publications, 2.1%
|
|
University of Tennessee
8 publications, 2.1%
|
|
Yale University
7 publications, 1.84%
|
|
Johns Hopkins University
7 publications, 1.84%
|
|
Pennsylvania State University
7 publications, 1.84%
|
|
University of Toronto
7 publications, 1.84%
|
|
Norwegian Institute of Public Health
6 publications, 1.57%
|
|
Massachusetts General Hospital
6 publications, 1.57%
|
|
University at Buffalo, State University of New York
6 publications, 1.57%
|
|
University of Texas at Austin
6 publications, 1.57%
|
|
McMaster University
6 publications, 1.57%
|
|
University of Queensland
5 publications, 1.31%
|
|
New York University
5 publications, 1.31%
|
|
University of Washington
5 publications, 1.31%
|
|
University of Michigan
5 publications, 1.31%
|
|
Emory University
5 publications, 1.31%
|
|
University of Texas Health Science Center at Houston
5 publications, 1.31%
|
|
University of New South Wales
4 publications, 1.05%
|
|
Aarhus University
4 publications, 1.05%
|
|
University of Bergen
4 publications, 1.05%
|
|
University of Southern California
4 publications, 1.05%
|
|
University of Botswana
4 publications, 1.05%
|
|
Western Michigan University
4 publications, 1.05%
|
|
University of Minnesota
4 publications, 1.05%
|
|
University of Wisconsin–Milwaukee
4 publications, 1.05%
|
|
University of Wisconsin–Madison
4 publications, 1.05%
|
|
University of Maryland, College Park
4 publications, 1.05%
|
|
University of Pennsylvania
4 publications, 1.05%
|
|
Western University
4 publications, 1.05%
|
|
University of Saskatchewan
4 publications, 1.05%
|
|
University of Kentucky
4 publications, 1.05%
|
|
University of Nevada, Las Vegas
4 publications, 1.05%
|
|
University of North Carolina at Chapel Hill
4 publications, 1.05%
|
|
University of Connecticut Health
4 publications, 1.05%
|
|
University of Connecticut
4 publications, 1.05%
|
|
Centre for Addiction and Mental Health
4 publications, 1.05%
|
|
Norwegian University of Science and Technology
3 publications, 0.79%
|
|
Haukeland University Hospital
3 publications, 0.79%
|
|
University of South-Eastern Norway
3 publications, 0.79%
|
|
University of South Australia
3 publications, 0.79%
|
|
Columbia University
3 publications, 0.79%
|
|
University of California, Berkeley
3 publications, 0.79%
|
|
New York University Langone Health
3 publications, 0.79%
|
|
Ohio University
3 publications, 0.79%
|
|
McGill University
3 publications, 0.79%
|
|
Duquesne University
3 publications, 0.79%
|
|
University of Colorado Boulder
3 publications, 0.79%
|
|
University of Rhode Island
3 publications, 0.79%
|
|
Texas A&M University
3 publications, 0.79%
|
|
University of Utah
3 publications, 0.79%
|
|
University of New England
3 publications, 0.79%
|
|
Shahid Sadoughi University of Medical Sciences
2 publications, 0.52%
|
|
Karolinska Institute
2 publications, 0.52%
|
|
Karlstad University
2 publications, 0.52%
|
|
University College London
2 publications, 0.52%
|
|
Finnish Institute for Health and Welfare
2 publications, 0.52%
|
|
University of Copenhagen
2 publications, 0.52%
|
|
UiT The Arctic University of Norway
2 publications, 0.52%
|
|
King's College London
2 publications, 0.52%
|
|
St Olav's University Hospital
2 publications, 0.52%
|
|
National University of Singapore
2 publications, 0.52%
|
|
University of Otago
2 publications, 0.52%
|
|
University of Western Australia
2 publications, 0.52%
|
|
Stanford University
2 publications, 0.52%
|
|
University of KwaZulu-Natal
2 publications, 0.52%
|
|
Case Western Reserve University
2 publications, 0.52%
|
|
Syracuse University
2 publications, 0.52%
|
|
California Pacific Medical Center
2 publications, 0.52%
|
|
Northern Illinois University
2 publications, 0.52%
|
|
Northeastern University
2 publications, 0.52%
|
|
Albert Einstein College of Medicine
2 publications, 0.52%
|
|
Aristotle University of Thessaloniki
2 publications, 0.52%
|
|
Trinity College Dublin
2 publications, 0.52%
|
|
Université de Sherbrooke
2 publications, 0.52%
|
|
University of British Columbia
2 publications, 0.52%
|
|
University of Minnesota Duluth
2 publications, 0.52%
|
|
Purdue University
2 publications, 0.52%
|
|
Medical College of Wisconsin
2 publications, 0.52%
|
|
University of Maryland, Baltimore
2 publications, 0.52%
|
|
York University
2 publications, 0.52%
|
|
University of Victoria
2 publications, 0.52%
|
|
University of Calgary
2 publications, 0.52%
|
|
University of Florida
2 publications, 0.52%
|
|
University of Cincinnati
2 publications, 0.52%
|
|
University of Rochester Medical Center
2 publications, 0.52%
|
|
University of Colorado Denver
2 publications, 0.52%
|
|
University of Texas Medical Branch
2 publications, 0.52%
|
|
National Institutes of Health Clinical Center
2 publications, 0.52%
|
|
University of Lethbridge
2 publications, 0.52%
|
|
Douglas Mental Health University Institute
2 publications, 0.52%
|
|
Tehran University of Medical Sciences
1 publication, 0.26%
|
|
Kharazmi University
1 publication, 0.26%
|
|
Akdeniz University
1 publication, 0.26%
|
|
Show all (70 more) | |
2
4
6
8
10
12
14
16
|
Publishing organizations in 5 years
1
2
3
4
|
|
Boston University
4 publications, 2.19%
|
|
University at Buffalo, State University of New York
4 publications, 2.19%
|
|
New York University
3 publications, 1.64%
|
|
University of California, San Francisco
3 publications, 1.64%
|
|
McMaster University
3 publications, 1.64%
|
|
Western University
3 publications, 1.64%
|
|
University of Toronto
3 publications, 1.64%
|
|
University of Saskatchewan
3 publications, 1.64%
|
|
University of North Carolina at Chapel Hill
3 publications, 1.64%
|
|
Shahid Sadoughi University of Medical Sciences
2 publications, 1.09%
|
|
Oslo University Hospital
2 publications, 1.09%
|
|
King's College London
2 publications, 1.09%
|
|
Norwegian Institute of Public Health
2 publications, 1.09%
|
|
National University of Singapore
2 publications, 1.09%
|
|
Johns Hopkins University
2 publications, 1.09%
|
|
Pennsylvania State University
2 publications, 1.09%
|
|
University of Queensland
2 publications, 1.09%
|
|
Columbia University
2 publications, 1.09%
|
|
University of KwaZulu-Natal
2 publications, 1.09%
|
|
Harvard University
2 publications, 1.09%
|
|
New York University Langone Health
2 publications, 1.09%
|
|
University of Washington
2 publications, 1.09%
|
|
University of Botswana
2 publications, 1.09%
|
|
University of Minnesota
2 publications, 1.09%
|
|
Medical College of Wisconsin
2 publications, 1.09%
|
|
York University
2 publications, 1.09%
|
|
University of Kentucky
2 publications, 1.09%
|
|
University of Nevada, Las Vegas
2 publications, 1.09%
|
|
Centre for Addiction and Mental Health
2 publications, 1.09%
|
|
University of Lethbridge
2 publications, 1.09%
|
|
Tehran University of Medical Sciences
1 publication, 0.55%
|
|
Kharazmi University
1 publication, 0.55%
|
|
Akdeniz University
1 publication, 0.55%
|
|
University of Lahore
1 publication, 0.55%
|
|
Uskudar University
1 publication, 0.55%
|
|
Fatima Jinnah Women University
1 publication, 0.55%
|
|
Mersin University
1 publication, 0.55%
|
|
Duy Tan University
1 publication, 0.55%
|
|
Iran University of Medical Sciences
1 publication, 0.55%
|
|
Hanoi School Of Public Health
1 publication, 0.55%
|
|
University of Da Nang
1 publication, 0.55%
|
|
Tel Aviv University
1 publication, 0.55%
|
|
Hebrew University of Jerusalem
1 publication, 0.55%
|
|
Ben-Gurion University of the Negev
1 publication, 0.55%
|
|
Sheba Medical Center
1 publication, 0.55%
|
|
Tel Aviv Sourasky Medical Center
1 publication, 0.55%
|
|
Ghent University
1 publication, 0.55%
|
|
National University of Malaysia
1 publication, 0.55%
|
|
Uppsala University
1 publication, 0.55%
|
|
Uppsala University Hospital
1 publication, 0.55%
|
|
Lausanne University Hospital
1 publication, 0.55%
|
|
University of New South Wales
1 publication, 0.55%
|
|
American University of Beirut
1 publication, 0.55%
|
|
Durham University
1 publication, 0.55%
|
|
Aston University
1 publication, 0.55%
|
|
Norwegian University of Science and Technology
1 publication, 0.55%
|
|
University of Bergen
1 publication, 0.55%
|
|
UiT The Arctic University of Norway
1 publication, 0.55%
|
|
University of Southern Denmark
1 publication, 0.55%
|
|
London School of Economics and Political Science
1 publication, 0.55%
|
|
Haukeland University Hospital
1 publication, 0.55%
|
|
St Olav's University Hospital
1 publication, 0.55%
|
|
University of Southern California
1 publication, 0.55%
|
|
Yale University
1 publication, 0.55%
|
|
Stavanger University Hospital
1 publication, 0.55%
|
|
University of Stavanger
1 publication, 0.55%
|
|
University of South-Eastern Norway
1 publication, 0.55%
|
|
University of Canterbury
1 publication, 0.55%
|
|
James Cook University
1 publication, 0.55%
|
|
North-West University
1 publication, 0.55%
|
|
University of Limpopo
1 publication, 0.55%
|
|
University of Lagos
1 publication, 0.55%
|
|
Dalhousie University
1 publication, 0.55%
|
|
Clemson University
1 publication, 0.55%
|
|
University of Illinois at Chicago
1 publication, 0.55%
|
|
Duke University Hospital
1 publication, 0.55%
|
|
Syracuse University
1 publication, 0.55%
|
|
Massachusetts General Hospital
1 publication, 0.55%
|
|
Brigham and Women's Hospital
1 publication, 0.55%
|
|
Tufts University
1 publication, 0.55%
|
|
University of California, Los Angeles
1 publication, 0.55%
|
|
University of California, San Diego
1 publication, 0.55%
|
|
San Diego State University
1 publication, 0.55%
|
|
Newcastle University
1 publication, 0.55%
|
|
University of Chicago
1 publication, 0.55%
|
|
De La Salle University
1 publication, 0.55%
|
|
University of Illinois Urbana-Champaign
1 publication, 0.55%
|
|
University of Michigan
1 publication, 0.55%
|
|
McGill University
1 publication, 0.55%
|
|
Université de Sherbrooke
1 publication, 0.55%
|
|
Tulane University
1 publication, 0.55%
|
|
University of Waterloo
1 publication, 0.55%
|
|
University of Minnesota Duluth
1 publication, 0.55%
|
|
Purdue University
1 publication, 0.55%
|
|
Brown University
1 publication, 0.55%
|
|
Salale University
1 publication, 0.55%
|
|
University of Wisconsin–Milwaukee
1 publication, 0.55%
|
|
University of Wisconsin–Madison
1 publication, 0.55%
|
|
University of Maryland, Baltimore
1 publication, 0.55%
|
|
University of Maryland Eastern Shore
1 publication, 0.55%
|
|
Show all (70 more) | |
1
2
3
4
|
Publishing countries
50
100
150
200
250
|
|
USA
|
USA, 220, 57.74%
USA
220 publications, 57.74%
|
Canada
|
Canada, 38, 9.97%
Canada
38 publications, 9.97%
|
Norway
|
Norway, 36, 9.45%
Norway
36 publications, 9.45%
|
Australia
|
Australia, 17, 4.46%
Australia
17 publications, 4.46%
|
United Kingdom
|
United Kingdom, 13, 3.41%
United Kingdom
13 publications, 3.41%
|
Ethiopia
|
Ethiopia, 8, 2.1%
Ethiopia
8 publications, 2.1%
|
Denmark
|
Denmark, 6, 1.57%
Denmark
6 publications, 1.57%
|
Sweden
|
Sweden, 6, 1.57%
Sweden
6 publications, 1.57%
|
Greece
|
Greece, 5, 1.31%
Greece
5 publications, 1.31%
|
Ireland
|
Ireland, 5, 1.31%
Ireland
5 publications, 1.31%
|
New Zealand
|
New Zealand, 5, 1.31%
New Zealand
5 publications, 1.31%
|
South Africa
|
South Africa, 5, 1.31%
South Africa
5 publications, 1.31%
|
Botswana
|
Botswana, 4, 1.05%
Botswana
4 publications, 1.05%
|
Brazil
|
Brazil, 4, 1.05%
Brazil
4 publications, 1.05%
|
India
|
India, 4, 1.05%
India
4 publications, 1.05%
|
Iran
|
Iran, 4, 1.05%
Iran
4 publications, 1.05%
|
Germany
|
Germany, 3, 0.79%
Germany
3 publications, 0.79%
|
Vietnam
|
Vietnam, 3, 0.79%
Vietnam
3 publications, 0.79%
|
Spain
|
Spain, 3, 0.79%
Spain
3 publications, 0.79%
|
Italy
|
Italy, 3, 0.79%
Italy
3 publications, 0.79%
|
Nigeria
|
Nigeria, 3, 0.79%
Nigeria
3 publications, 0.79%
|
Netherlands
|
Netherlands, 3, 0.79%
Netherlands
3 publications, 0.79%
|
Singapore
|
Singapore, 3, 0.79%
Singapore
3 publications, 0.79%
|
Switzerland
|
Switzerland, 3, 0.79%
Switzerland
3 publications, 0.79%
|
Israel
|
Israel, 2, 0.52%
Israel
2 publications, 0.52%
|
Iceland
|
Iceland, 2, 0.52%
Iceland
2 publications, 0.52%
|
Turkey
|
Turkey, 2, 0.52%
Turkey
2 publications, 0.52%
|
Finland
|
Finland, 2, 0.52%
Finland
2 publications, 0.52%
|
Japan
|
Japan, 2, 0.52%
Japan
2 publications, 0.52%
|
France
|
France, 1, 0.26%
France
1 publication, 0.26%
|
Estonia
|
Estonia, 1, 0.26%
Estonia
1 publication, 0.26%
|
China
|
China, 1, 0.26%
China
1 publication, 0.26%
|
Austria
|
Austria, 1, 0.26%
Austria
1 publication, 0.26%
|
Aruba
|
Aruba, 1, 0.26%
Aruba
1 publication, 0.26%
|
Belgium
|
Belgium, 1, 0.26%
Belgium
1 publication, 0.26%
|
Cyprus
|
Cyprus, 1, 0.26%
Cyprus
1 publication, 0.26%
|
Lebanon
|
Lebanon, 1, 0.26%
Lebanon
1 publication, 0.26%
|
Malaysia
|
Malaysia, 1, 0.26%
Malaysia
1 publication, 0.26%
|
Mexico
|
Mexico, 1, 0.26%
Mexico
1 publication, 0.26%
|
Pakistan
|
Pakistan, 1, 0.26%
Pakistan
1 publication, 0.26%
|
Peru
|
Peru, 1, 0.26%
Peru
1 publication, 0.26%
|
Thailand
|
Thailand, 1, 0.26%
Thailand
1 publication, 0.26%
|
Uganda
|
Uganda, 1, 0.26%
Uganda
1 publication, 0.26%
|
Philippines
|
Philippines, 1, 0.26%
Philippines
1 publication, 0.26%
|
Sri Lanka
|
Sri Lanka, 1, 0.26%
Sri Lanka
1 publication, 0.26%
|
Show all (15 more) | |
50
100
150
200
250
|
Publishing countries in 5 years
10
20
30
40
50
60
70
|
|
USA
|
USA, 65, 35.52%
USA
65 publications, 35.52%
|
Canada
|
Canada, 18, 9.84%
Canada
18 publications, 9.84%
|
Norway
|
Norway, 7, 3.83%
Norway
7 publications, 3.83%
|
Ethiopia
|
Ethiopia, 7, 3.83%
Ethiopia
7 publications, 3.83%
|
United Kingdom
|
United Kingdom, 5, 2.73%
United Kingdom
5 publications, 2.73%
|
South Africa
|
South Africa, 4, 2.19%
South Africa
4 publications, 2.19%
|
Australia
|
Australia, 3, 1.64%
Australia
3 publications, 1.64%
|
Iran
|
Iran, 3, 1.64%
Iran
3 publications, 1.64%
|
Singapore
|
Singapore, 3, 1.64%
Singapore
3 publications, 1.64%
|
Botswana
|
Botswana, 2, 1.09%
Botswana
2 publications, 1.09%
|
Brazil
|
Brazil, 2, 1.09%
Brazil
2 publications, 1.09%
|
Vietnam
|
Vietnam, 2, 1.09%
Vietnam
2 publications, 1.09%
|
Israel
|
Israel, 2, 1.09%
Israel
2 publications, 1.09%
|
Spain
|
Spain, 2, 1.09%
Spain
2 publications, 1.09%
|
Netherlands
|
Netherlands, 2, 1.09%
Netherlands
2 publications, 1.09%
|
Turkey
|
Turkey, 2, 1.09%
Turkey
2 publications, 1.09%
|
France
|
France, 1, 0.55%
France
1 publication, 0.55%
|
Aruba
|
Aruba, 1, 0.55%
Aruba
1 publication, 0.55%
|
Belgium
|
Belgium, 1, 0.55%
Belgium
1 publication, 0.55%
|
Denmark
|
Denmark, 1, 0.55%
Denmark
1 publication, 0.55%
|
Ireland
|
Ireland, 1, 0.55%
Ireland
1 publication, 0.55%
|
Italy
|
Italy, 1, 0.55%
Italy
1 publication, 0.55%
|
Lebanon
|
Lebanon, 1, 0.55%
Lebanon
1 publication, 0.55%
|
Malaysia
|
Malaysia, 1, 0.55%
Malaysia
1 publication, 0.55%
|
Nigeria
|
Nigeria, 1, 0.55%
Nigeria
1 publication, 0.55%
|
New Zealand
|
New Zealand, 1, 0.55%
New Zealand
1 publication, 0.55%
|
Pakistan
|
Pakistan, 1, 0.55%
Pakistan
1 publication, 0.55%
|
Peru
|
Peru, 1, 0.55%
Peru
1 publication, 0.55%
|
Philippines
|
Philippines, 1, 0.55%
Philippines
1 publication, 0.55%
|
Switzerland
|
Switzerland, 1, 0.55%
Switzerland
1 publication, 0.55%
|
Sweden
|
Sweden, 1, 0.55%
Sweden
1 publication, 0.55%
|
Sri Lanka
|
Sri Lanka, 1, 0.55%
Sri Lanka
1 publication, 0.55%
|
Show all (2 more) | |
10
20
30
40
50
60
70
|